Status | Study |
Completed |
Study Name: A Study to Evaluate 4-year Antibody Persistence and Booster Response Following MenABCWY Vaccination in Healthy Adolescents and Young Adults Who Previously Participated in Studies V102_02 (NCT01210885) and V102_02E1 (NCT01367158) Condition: Meningococcal Disease Date: 2015-05-04 Interventions: Biological: MenABCWY+OMV vaccine Intramuscular injection of a single dose at Day 1 to subjects in the Me |
Active, not recruiting |
Study Name: Investigating Meningococcal Vaccines in Adults Condition: Meningococcal Vaccines Meningococcal Infections Neisseria Date: 2015-03-20 Interventions: Biological: 4CMenB (Bexsero®) - Novartis Vaccines and Diagnostics 4CMenB vaccine (Bexsero - Novarti |
Completed |
Study Name: Assessing the Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents Condition: Meningococcal Disease Date: 2014-11-05 Interventions: Biological: Meningococcal ABCWY |
Active, not recruiting |
Study Name: Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Infant Study Condition: Meningococcal Disease Date: 2014-10-27 Interventions: Biological: Meningococcal quadrivalent CRM-197 conjugate vaccine This study is strictly observational. D |
Recruiting |
Study Name: Meningococcal Quadrivalent CRM-197 Conjugate Vaccine Pregnancy Registry Condition: Meningococcal Disease Pregnancy Date: 2014-08-20 Interventions: Biological: Meningococcal quadrivalent CRM-197 conjugate vaccine This pregnancy registry is strictly obs |
Completed |
Study Name: Trial to Assess Immunogenicity and Safety of Novartis Meningococcal ABCWY Vaccine as Compared to Meningococcal B Vaccine in Adolescents Condition: Meningococcal Disease Date: 2014-08-06 Interventions: Biological: rMenB+OMV Other: Placebo |
Completed |
Study Name: Safety and Immunogenicity of Novartis Meningococcal B Recombinant Vaccine When Administered Concomitantly With Routine Vaccines to Healthy Infants of 2 Months of Age and Older, in Taiwan. Condition: Meningococcal Disease Date: 2014-06-05 Interventions: Biological: Bexsero® Four |
Completed |
Study Name: Safety and Immunogenicity of Novartis Meningococcal B Vaccine When Administered to Immunocompromised Children and Adolescents Compared to Healthy Subjects. Condition: Meningococcal Disease Date: 2014-05-15 Interventions: Biological: rMenB+OMV 2 doses of vaccine 2 months apart |
Completed |
Study Name: Effectiveness, Immunogenicity and Safety of Meningococcal ABCWY Vaccine Administered to Healthy Adolescents Condition: Meningococcal Disease Date: 2014-05-06 Interventions: Biological: MenABCWY Effective |
Completed |
Study Name: Safety and Immunogenicity of Novartis Meningococcal Group B Vaccine When Administered Concomitantly With Novartis MenACWY Conjugate Vaccine to Healthy Infants Condition: Infections, Meningococcal Date: 2014-02-14 Interventions: Biological: Meningococcal group B Vaccine, rMenB+OMV NZ |